WASHINGTON -- In its first vote on stem cell research since President Bush imposed restrictions on federal funding nearly four years ago, the US House of Representatives today is expected to defy a presidential veto threat and pass legislation permitting taxpayer dollars to underwrite research using unneeded embryos from fertility clinics. (Full article: 700 words)
This article is available in our archives:
Globe Subscribers
FREE for subscribers
Subscribers to the Boston Globe get unlimited access to our archives.
Not a subscriber?
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $4.95 1 article
- $9.95 4 articles
- $25.95 Monthly
Waiting on Twitter...